Literature DB >> 7673646

Control of methicillin-resistant Staphylococcus aureus in a hospital and an intensive care unit.

A I Hartstein1, M A Denny, V H Morthland, A M LeMonte, M A Pfaller.   

Abstract

OBJECTIVE: To describe methicillin-resistant Staphylococcus aureus (MRSA) control in a hospital, including a surgical intensive care unit (SICU) outbreak.
DESIGN: Prospective surveillance of newly identified patients with MRSA. Barrier isolation (disposable gloves for direct contact with patient or immediate environment) was used for the routine care of hospitalized MRSA patients as of October 1991. Beginning in 1992, MRSA isolates were typed by restriction endonuclease enzyme analysis of plasmid DNA (REAP) and/or pulsed-field gel electrophoresis of genomic DNA (PFGE). Surveillance information and MRSA typing were used concurrently to identify nosocomial case clustering, confirm cross-infection, and support a need for additional outbreak control interventions.
SETTING: University-affiliated public hospital. PARTICIPANTS: Patients with newly identified MRSA colonization or infection from 1991 through 1993 and epidemiologically associated staff providing care to eight SICU patients in an outbreak.
INTERVENTIONS: Barrier isolation for affected and unaffected patients in and admitted to the SICU institution when the outbreak was identified and cross-infection confirmed. Anterior nares cultures of staff in contact with outbreak cases for detection of MRSA colonization.
RESULTS: Fifty-six hospitalized patients with community-acquired MRSA and 80 patients with nosocomial MRSA colonization or infection were identified during the 3 years. After the introduction of barrier isolation, the annual frequency of new nosocomial MRSA cases decreased and only one outbreak (eight cases in the SICU) caused by type-related isolates occurred. The other 35 nosocomial cases of MRSA during 1992 and 1993 were not epidemiologically related or were caused by isolates with different types. The SICU outbreak ended after instituting barrier isolation for all patients (with and without MRSA) in and admitted to the unit. Six colonized SICU staff were identified. All outbreak cases had identical or related MRSA types by PFGE and REAP. Staff isolates were different from case isolates by typing, and staff were not restricted and not given treatment for colonization. After more than 6 months of follow up, no further outbreaks of MRSA in the SICU or elsewhere in the hospital occurred despite returning to barrier isolation for affected patients only.
CONCLUSION: MRSA in hospitals and outbreaks of MRSA in ICUs can be controlled by surveillance and minimal barrier interventions. REAP or PFGE typing of MRSA can be used to support or refute the presence of cross-transmission. Typing also may be helpful when planning and assessing the effectiveness of interventions directed at endemic, as well as outbreak, MRSA control.

Entities:  

Mesh:

Year:  1995        PMID: 7673646     DOI: 10.1086/647138

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  14 in total

1.  Genetic relationship between methicillin-sensitive and methicillin-resistant Staphylococcus aureus strains from France and from international sources: delineation of genomic groups.

Authors:  Catherine Branger; Carole Gardye; Jacques-Olivier Galdbart; Catherine Deschamps; Nicole Lambert
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

2.  Rotation of antimicrobial therapy in the intensive care unit: impact on incidence of ventilator-associated pneumonia caused by antibiotic-resistant Gram-negative bacteria.

Authors:  E Raineri; L Crema; S Dal Zoppo; A Acquarolo; A Pan; G Carnevale; F Albertario; A Candiani
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-04       Impact factor: 3.267

Review 3.  Hospital infection control strategies for vancomycin-resistant Enterococcus, methicillin-resistant Staphylococcus aureus and Clostridium difficile.

Authors:  B Lynn Johnston; Elizabeth Bryce
Journal:  CMAJ       Date:  2009-03-17       Impact factor: 8.262

4.  Analysis of an outbreak of non-phage-typeable methicillin-resistant Staphylococcus aureus by using a randomly amplified polymorphic DNA assay.

Authors:  A Tambic; E G Power; H Talsania; R M Anthony; G L French
Journal:  J Clin Microbiol       Date:  1997-12       Impact factor: 5.948

Review 5.  Gloves, gowns and masks for reducing the transmission of meticillin-resistant Staphylococcus aureus (MRSA) in the hospital setting.

Authors:  Jesús López-Alcalde; Marta Mateos-Mazón; Marcela Guevara; Lucieni O Conterno; Ivan Solà; Sheila Cabir Nunes; Xavier Bonfill Cosp
Journal:  Cochrane Database Syst Rev       Date:  2015-07-16

6.  Epidemiology and typing of Staphylococcus aureus strains isolated from bloodstream infections.

Authors:  Nathalie van der Mee-Marquet; Anne-Sophie Domelier; Nicole Girard; Roland Quentin
Journal:  J Clin Microbiol       Date:  2004-12       Impact factor: 5.948

7.  Occupational health and safety in small animal veterinary practice: Part I--nonparasitic zoonotic diseases.

Authors:  J S Weese; A S Peregrine; J Armstrong
Journal:  Can Vet J       Date:  2002-08       Impact factor: 1.008

8.  Implementing the MRSA recommendations made by the Commission for Hospital Hygiene and Infection Prevention (KRINKO) of 1999 - current considerations by the DGKH Management Board.

Authors:  Arne Simon; Martin Exner; Axel Kramer; Steffen Engelhart
Journal:  GMS Krankenhhyg Interdiszip       Date:  2009-04-09

9.  Rapid identification of hospitalized patients at high risk for MRSA carriage.

Authors:  R Scott Evans; Carrie Jane Wallace; James F Lloyd; Caroline W Taylor; Rouett H Abouzelof; Sharon Sumner; Kyle V Johnson; Amyanne Wuthrich; Stephan Harbarth; Matthew H Samore
Journal:  J Am Med Inform Assoc       Date:  2008-04-24       Impact factor: 4.497

10.  Ethics roundtable debate: A patient dies from an ICU-acquired infection related to methicillin-resistant Staphylococcus aureus--how do you defend your case and your team?

Authors:  Jean-Louis Vincent; Christian Brun-Buisson; Michael Niederman; Christian Haenni; Stephan Harbarth; Dominique Sprumont; Mauricio Valencia; Antoni Torres
Journal:  Crit Care       Date:  2004-12-15       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.